Clinical trials for Bird flu

Information provided by WHO International Clinical Trials Registry

The clinical trials below are relevant to Bird flu. For all clinical trials, go to clinical trials search

This list shows clinical trials for Bird flu

Search result filters
Recruitment status
Trials for children:
Country of trial:

You have searched for the following terms

  • Bird flu
Title Recruitment status Location
Safety and Immunogenicity of Two Doses of H5N1 Influenza Vaccine in Adults Unprimed and Primed With Adjuvanted or Non-adjuvanted Influenza Vaccines Not recruiting United Kingdom
High-Dose Versus Standard-Dose Oseltamivir to Treat Severe Influenza and Avian Influenza Not recruiting United Kingdom
A Phase II, Multicenter, Exploratory Study to Evaluate Safety and Immunogenicity of Two Doses of FLUAD-H5N1 Influenza Vaccine in Adults Unprimed and Primed with MF59-adjuvanted or Non-adjuvanted H5N3 Influenza Vaccines. Authorised United Kingdom
A Phase II, Randomized, Partially observer-blind, Single-centre study to Evaluate Safety and Immunogenicity of MF59-adjuvanted or Non-adjuvanted H5N1 Booster Influenza Vaccines in Adults Primed with MF59-adjuvanted A/Vietnam/1194/04 (H5N1) vaccine - Prime-boost vaccination using H5N1 vaccines Authorised United Kingdom
Evaluation of Clinical Effectiveness of High-dose Intravenous Immunoglobulin(HD-IVIg) Therapy in Pneumonia with Avian Influenza and Other Influenza Recruiting Japan,Asia(except Japan)
Immunogenicity of Monovalent Inactivated Influenza A/H7N9 Virus Vaccine. Recruiting United States
Preliminary study on recombinant human soluble thrombomodulin (rTM) administration for treatment of pneumonia-induced acute respiratory distress syndrome (ARDS) complicated with disseminated intravascular coagulation(DIC) and sepsis, including avian influenza virus infection Recruiting Asia(except Japan)
H5N8 Mix and Match With or Without AS03 or MF59 in Healthy Adults Recruiting United States
A Phase I Study Priming With an Inactivated A/H7N9 Influenza Virus Vaccine With or Without MF59 Adjuvant Followed by Live Attenuated A/H7N9 Influenza Virus Vaccine Recruiting United States
Efficacy and safety of the avian influenza A/H7N9 inactivated whole-virus vaccine produced using the embryonated egg in human (Investigator-initiated Phase 2b trial) Recruiting Japan

Page last reviewed: 28/05/2015

Next review due: 30/06/2017